$56 million investment in Cancer and Inflammatory Disease medicines

The Morrison Government will invest $56 million that will provide affordable access to four new medicine listings through the Pharmaceutical Benefits Scheme (PBS), helping patients fighting aggressive forms of cancer and inflammatory conditions.   Under the PBS, treatment for brain tumours, leukaemia and inflammatory disease of the large blood vessels will be available to patients…

2GB interview with Steve Price

E&OE…             Topics: Private Health Insurance.   STEVE PRICE: A lot of debate, and a lot of it centres around the fact that youngsters are not signing up to private health insurance.   Well, the Federal Health Minister has ruled out, as I just mentioned, the scrapping of Medicare.   It was used as a…

Doorstop – Canberra

E&OE…                       Topics: AMA Informed Financial Consent Guide; Medicare rebate; fee transparency website   TONY BARTONE: Welcome everyone. Thank you for being here this morning and good morning.   Thank you to Minister Hunt for launching our Informed Financial Consent – a collaboration between doctors and patients (inaudible) today.   Today’s announcement is all about…

Informed Financial Consent (IFC) guide – Launched

The Morrison Government and the Australian Medical Association (AMA) has today jointly launched a new guide that aims to better aid Australians when faced with making decisions around medical treatments.   The AMA’s Informed Financial Consent Guide; A Collaboration Between Doctors and Patients will help patients better understand medical treatment fees and out of pocket…

Doorstop – Melbourne

E&OE…                       Topics: Infants with Cystic Fibrosis to breathe easier with new PBS listing; Temporary Exclusion Orders Bill; Newstart allowance.   DAVID ARMSTRONG: Good morning everybody. Welcome to Monash Children’s Hospital. I’m David Armstrong, Head of the Paediatric CF Service.   It’s my pleasure to welcome Nettie Burke the CEO of Cystic Fibrosis Australia, the…

Infants with Cystic Fibrosis to breathe easier with new PBS listing

The Morrison Government is expanding access to a critically important medicine on the Pharmaceutical Benefits Scheme (PBS) that will help infants living with Cystic Fibrosis and save their families up to $300,000 per year.   From 1 August, the medicine Kalydeco® (ivacaftor), will made available through the PBS for patients aged 12 to 24 months…

$21 million for dementia research

The Morrison Government will provide $21 million for 13 research projects that will focus on risk reduction, prevention and tracking of dementia, Australia’s second leading cause of death.   This brings the total investment under the National Health and Medical Research Council’s (NHMRC) Boosting Dementia Research Grant scheme to $200 million.   Two dementia research…

New National Centre for Healthy Ageing

A funding agreement between the Morrison Government, Monash University and Peninsula Health will see a National Centre for Healthy Ageing at Monash University’s Peninsula campus.   Following the 2019-20 Budget announcement of a $32 million contribution from the Government for the National Centre for Healthy Ageing, a project agreement has been signed and the first…

A $2.8 million focus on Diabetes

The Morrison Government is committed to tackling diabetes and is investing $2.8 million to help prevent and treat diabetes-related blindness and foot complications. Diabetes is a chronic condition that impacts the lives of more than 1.2 million Australians. Coinciding with National Diabetes Week, Morrison Government funding will support two new programs: $1.5 million will be…

Proposed Regulatory Action for Textured Breast Implants

Australia’s medical device regulator, has today announced that it is proposing to take strong and decisive action to suspend or cancel and recall certain textured breast implants from the Australian Market, following a review of apparent links to rare forms of cancer.   The Therapeutic Goods Administration (TGA) proposed regulatory action follows an extensive review…